Dr Joanna Redmond

Dr Joanna Redmond
Dr Joanna Redmond
Scientific Leader
GlaxoSmithKline
Speaker

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Profile of Dr Joanna Redmond

Jo Redmond is a Scientific Leader in the Chemical Biology group at GSK, where she leads the Chemogenomic screening platform and its application to support target identification for drug discovery programs.
Jo joined GSK as a Medicinal Chemist in 2008 and has led Medicinal Chemistry efforts for kinase, integrin and GPCR-based drug discovery programs. These projects have included small molecule modulators and PROTACs, spanning both hit-to-lead and lead optimisation activities. From 2017 to 2019 she worked at the Francis Crick Institute in the GSK/Crick LinkLabs as a Medicinal Chemistry Leader and developed an approach utilising orally bioavailable small molecule “bumped” kinase inhibitors in conjunction with targeted genetic mutation to explore full organism kinase biology. Prior to joining GSK, Jo completed a PhD in stereoselective synthesis at Imperial College London and a Masters in Chemistry at the University of Oxford.

Colleagues

Dr Daren Austin
GlaxoSmithKline
Dr Anthony Bahinski
Global Head, Safety Pharmacology
GlaxoSmithKline
David Battersby
GlaxoSmithKline
Mr Darren Rimmer
Scientific Leader
GlaxoSmithKline
Mr Stephen Vitale
Sr Scientist
GlaxoSmithKline

Email

Please login to send a Private Message

Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021